Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Author: healthadmin
A large-scale computational study by researchers at the University of Jyväskylä (Finland) predicted that gold nanoclusters can selectively recognize chiral biomolecules. This property could be useful in detecting certain diseases directly from blood samples. Gold nanoclusters are atomically precise nanostructures with sizes of a few nanometers. They contain a metallic gold core, protected by a layer of organic ligand molecules. The chemical nature of the ligand molecules determines the solubility of the cluster in different environments and enables the functionality of the cluster’s outer organic surface and its interaction with the environment. Helical surface allows recognition of helical biomolecules The…
Climate change is fueling a public health emergency with rising heat deaths, air pollution, and vector-borne diseases in urban areas. Discover adaptation gaps and sustainable strategies for resilient cities.
State signs PFAS testing agreements with four southern New Mexico dairy farms | Local News
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington, D.C. West Virginia Wisconsin Wyoming Puerto Rico U.S. Virgin Islands U.S. Army Pacific Command Europe Northern Mariana Islands Marshall Islands American Samoa Micro Canada Guam Palau Alberta, Canada British Columbia, Canada Manitoba Canada, New Brunswick Canada, Canada Newfoundland Canada, Canada Nova Scotia Canada, Canada Northwest…
New psychological research reveals we consistently underestimate our power in intimate relationships
New research published in Personality and Social Psychology Bulletin It suggests that people always underestimate how much influence they have over their lovers and friends. This misperception tends to be stronger for people who are highly focused on protecting themselves and maintaining control, providing evidence that personal insecurities shape the way we view our intimate relationships. By recognizing this hidden influence, individuals may find healthier ways to communicate and resolve conflicts with loved ones. In psychological research, power is defined as the perceived ability to guide mutual decisions and meet personal needs rather than simply controlling others. Previous research has…
Written by Darcy LewisSponsored by Abarca HealthPrior authorization (PA), where access, cost, and patient experience are met, has long been considered by many to be a necessary evil in efforts to contain U.S. pharmacy costs while improving clinical outcomes. But what if we could imagine a less frictional PA process that brought payers, pharmacy benefits managers (PBMs), specialty pharmacies, and clinicians together in the same room to solve problems rather than create them?The invitation-only Abarca Forward Conference, hosted by PBM Abarca Health at its headquarters in San Juan, Puerto Rico, did just that. This problem consists of two important concepts.…
Physicians who treat sickle cell disease face some of the most complex and resource-intensive treatments in medicine, and national surveys show significantly higher levels of physician burnout, raising concerns about workforce sustainability and patient care. study: Burnout among physicians trained in hematology-oncology with a focus on sickle cell disease: A national cross-sectional study. Image credit: Monika Wisniewska/Shutterstock.com Approximately half of U.S. physicians experience burnout, threatening the quality of care and personal fulfillment. Among U.S. hematology-oncology physicians, those who specialize in sickle cell disease (SCD) are more likely to experience burnout, according to a study published today. Blood Advances. The authors…
A new clinical trial led by the Oncology Clinical Trials Alliance will investigate whether combination drug therapy after radiation therapy improves outcomes for patients newly diagnosed with grade 3 IDH-mutant astrocytoma, a type of brain tumor. The study (Alliance A072301), supported in part by a grant from the National Cancer Institute, will examine whether adding the oral drug vorasidenib to standard oral chemotherapy can prevent cancer recurrence after radiation therapy. People diagnosed with IDH-mutated grade 3 astrocytoma usually undergo surgery, followed by radiation therapy and the oral chemotherapy drug temozolomide. Temozolomide works by damaging the DNA of tumor cells, making…
A new randomized clinical trial suggests that just 24 minutes of listening to specially designed music can significantly reduce anxiety. This music was combined with auditory beat stimulation (ABS), a technique that uses rhythmic sound patterns to influence brain activity. Researchers say this approach could provide an accessible, drug-free option for people looking for additional ways to manage stress and regulate their emotions. The clinical trial was conducted by psychology researchers Daniel K. Mullen and Frank A. Russo at Toronto Metropolitan University (TMU) in partnership with LUCID, a digital therapeutics company born out of TMU’s Zone Learning ecosystem. Music-based therapy…
New release of Wiley’s Mass Spectra of Designer Drugs 2026 expands coverage of new novel psychoactive substances
Wiley, the world leader in trusted content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced its 2026 release. Mass spectrum of designer drugsis an important GC-MS spectral database used by forensic laboratories around the world to quickly identify illegal substances. As the novel psychoactive substances (NPS) landscape continues to evolve, with an increasing number of synthetic cannabinoids, metabolites, fentanyl analogs, pharmaceuticals and metabolites, derivatives, and other emerging compounds, laboratories rely on continuously updated reference data to keep pace. The latest release includes updates to ensure comprehensive and up-to-date support for forensic, toxicology, and drug…
Psilocybin may not be the most psychoactive ingredient in magic mushrooms, new research suggests
New research published in scientific report This suggests that the therapeutic effects of psychedelic mushrooms likely depend on complex interactions of multiple compounds, rather than just a single active ingredient. Scientists have found evidence that several trace compounds in these mushrooms work together to interact with receptors in the brain, potentially explaining why natural extracts often produce different effects than synthetic extracts. Psychedelic mushrooms, often called magic mushrooms, belong to a group of fungi that naturally produce mind-altering chemicals. These fungi have been used in spiritual rituals for centuries and are now receiving mainstream medical attention. In clinical trials, these…